Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1413 Inhibitors

Olr1413 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the function of the Olr1413 receptor, an olfactory receptor that belongs to the G protein-coupled receptor (GPCR) superfamily. These receptors are key components of the olfactory system, which is responsible for detecting and processing odorant molecules, leading to the perception of smells. Olr1413 inhibitors work by binding to the receptor's active site, where natural odorant molecules would typically bind, or by interacting with allosteric sites that modulate the receptor's activity. This binding effectively prevents the receptor from undergoing the conformational changes necessary for activating downstream signaling pathways, thus blocking the receptor's ability to transmit olfactory signals. By inhibiting these processes, Olr1413 inhibitors disrupt the receptor's normal role in sensory perception, interfering with the detection and identification of odors. The development and design of these inhibitors often rely on detailed structural studies of the Olr1413 receptor, utilizing advanced techniques such as X-ray crystallography, molecular dynamics simulations, and cryo-electron microscopy. These techniques provide essential insights into the receptor's binding pockets and other critical structural features, enabling the creation of inhibitors that are highly specific to the Olr1413 receptor and effective in modulating its activity.

Chemically, Olr1413 inhibitors exhibit a diverse range of molecular structures, reflecting the various synthetic strategies employed in their development. These compounds can range from small, lipophilic molecules that easily penetrate cellular membranes to reach their target receptors, to larger, more complex structures that may require sophisticated synthetic pathways to achieve the desired binding affinity and specificity. The synthesis of Olr1413 inhibitors typically involves multiple steps of organic chemistry, including the construction of molecular frameworks and the incorporation of functional groups that enhance the compound's interaction with the receptor. Once synthesized, these inhibitors undergo rigorous characterization using a variety of analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods ensure that the inhibitors possess the desired structural integrity, purity, and inhibitory potency. The study of Olr1413 inhibitors is important not only for advancing our understanding of the specific mechanisms by which this olfactory receptor operates but also for contributing to the broader field of GPCR biology. By deepening our knowledge of how olfactory receptors function and how their activity can be selectively targeted, researchers can explore new directions in the study of sensory systems and the complex biochemical pathways that govern them. This research offers valuable insights into the molecular processes underlying sensory perception, particularly in the context of olfaction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-Baclofen

1134-47-0sc-200464
sc-200464A
1 g
5 g
$56.00
$258.00
(1)

GABA B receptor agonist, can indirectly affect GPCR signaling, potentially impacting Olr1413.

Cilnidipine

132203-70-4sc-201485
sc-201485A
sc-201485B
10 mg
50 mg
1 g
$74.00
$284.00
$450.00
1
(0)

Calcium channel blocker, may alter GPCR signaling by influencing calcium dynamics, impacting Olr1413.

12β-Hydroxydigitoxin

20830-75-5sc-213604
sc-213604A
1 g
5 g
$143.00
$694.00
(0)

Cardiac glycoside, could indirectly modulate GPCR signaling through its effects on heart function and electrolyte balance, impacting Olr1413.

Esmolol

81147-92-4sc-279019B
sc-279019A
sc-279019
50 mg
100 mg
500 mg
$100.00
$150.00
$650.00
1
(1)

Beta-1 adrenergic receptor antagonist, might modulate GPCR signaling pathways, potentially affecting Olr1413.

Felbamate

25451-15-4sc-203579
sc-203579A
10 mg
50 mg
$101.00
$373.00
(0)

Anticonvulsant, can indirectly affect GPCR signaling through its effects on neurotransmitter systems, potentially impacting Olr1413.

Guanfacine

29110-47-2sc-353618
200 mg
$1900.00
(0)

Alpha-2A adrenergic receptor agonist, could influence GPCR signaling, potentially impacting Olr1413.

Ivabradine hydrochloride

148849-67-6sc-507513
10 mg
$120.00
(0)

Heart rate lowering agent, can indirectly affect GPCR signaling through its cardiac effects, impacting Olr1413.

Tolvaptan

150683-30-0sc-364638
sc-364638A
10 mg
50 mg
$125.00
$624.00
(0)

Vasopressin receptor antagonist, can modulate GPCR signaling, potentially impacting Olr1413.